Equities

Fusion Antibodies PLC

FAB:LSE

Fusion Antibodies PLC

Health CareHealth Care Providers
  • Price (GBX)3.46
  • Today's Change0.06 / 1.76%
  • Shares traded187.56k
  • 1 Year change-91.35%
  • Beta0.4316
Data delayed at least 20 minutes, as of May 09 2024 10:32 BST.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Mar 31 2023202320222021
ASSETS
Cash And Short Term Investments0.202.052.69
Total Receivables, Net0.701.020.78
Total Inventory0.540.590.48
Prepaid expenses0.260.620.76
Other current assets, total------
Total current assets1.694.284.71
Property, plant & equipment, net0.380.631.12
Goodwill, net------
Intangibles, net000.00
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets2.064.925.83
LIABILITIES
Accounts payable0.480.470.34
Accrued expenses0.310.630.44
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.040.070.16
Other current liabilities, total0.050.050.05
Total current liabilities0.881.211.00
Total long term debt0.040.000.07
Total debt0.080.070.23
Deferred income tax------
Minority interest------
Other liabilities, total0.020.020.02
Total liabilities0.941.231.08
SHAREHOLDERS EQUITY
Common stock1.041.041.02
Additional paid-in capital7.657.657.55
Retained earnings (accumulated deficit)(7.56)(5)(3.82)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity1.123.684.75
Total liabilities & shareholders' equity2.064.925.83
Total common shares outstanding262626
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.